- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07892144
Effects of Low-Load Blood Flow Restriction Resistance Training With and Without Hip Abductor Strengthening in Patients With Knee Osteoarthritis (BFR) (yes)
Effects of Low-Load Blood Flow Restriction Resistance With and Without Hip Abductor Strength Training on Pain, Range of Motion, Strength and Function in Patients With Knee Osteoarthritis
This study aims to compare the effects of low-load Blood Flow Restriction (BFR) resistance training with and without hip abductor strengthening in patients with knee osteoarthritis. It will evaluate the effectiveness of both treatment approaches in reducing knee pain, improving range of motion, increasing muscle strength, and enhancing functional ability. The study will determine which intervention provides better clinical outcomes in patients with knee osteoarthritis.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- University of Management & Technology
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Both genders.
- Age 40-60 years.
- BMI (kg/m 2 ) < 30
- Have unilateral or bilateral knee OA.
- Have radiographic OA severity of Kellgren-Lawrence Grade I-II.
- Knee pain ≥3 months.
- Report pain intensity of ≥4-6/1 0 on NPRS
- Be able to walk independently without assistive devices
Exclusion Criteria:
- Total Knee replacement
- Deep venous thrombosis.
- Severe Cardiovascular disorders.(such as Acute myocardial
- infarction, peripheral arterial disease)
- Uncontrolled hypertension and diabetes.
- Acute knee injury within the last 6 months.
- Significant ligament tears (ACL, PCL, MCL, LCL).
- Knee surgery within the last 6-1 2 months.
- Lower limb Fractures
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Low-Load Blood Flow Restriction Resistance Training
|
Participants will receive supervised low-load BFR training targeting quadriceps and hamstrings through seated knee extensions, leg presses (bilateral/unilateral), and progressive mini squats at 20-30% of 1RM.Each exercise includes 4 sets (30-15-15-15 repetitions), with 30-60 seconds of rest between sets while the cuff remains inflated, followed by immediate deflation after the final set. |
|
Eksperimentel: Hip abductor strength training followed by low-load BFR resistance training
|
Participants will receive hip abductor strengthening for Weeks 2-4, followed by BFR resistance training during Weeks 5-6, under physiotherapist supervision. Exercises include side-lying hip abduction, clamshells, standing resisted hip abduction, and lateral band walks (3 sets of 10-15 repetitions or 10 lateral steps per direction), with 60-second rest intervals. Training will begin with bodyweight exercises, progressing to TheraBand resistance from Week 2, without BFR cuff application during hip exercises. Weeks 5-6: Participants will receive BFR training (knee extensions and leg presses) at 20-30% of 1RM, 70% arterial occlusion pressure (AOP), and 4 sets of 30-15-15-15 repetitions. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Numeric Pain Rating Scale
Tidsramme: Baseline and 6 weeks post treatment
|
11-point numeric with 0 representing No pain, 1-3 representing Mild Pain (nagging, annoying, interfering little with ADLs), 4-6 representing Moderate Pains (interferes significantly with ADLs), 7-10 representing Sever Pain |
Baseline and 6 weeks post treatment
|
|
Western Ontario And McMasters Universities Osteoarthritis Index
Tidsramme: Baseline and 6 weeks post treatment
|
The WOMAC is a disease-specific questionnaire designed to assess symptoms and functional limitations in individuals with knee and hip osteoarthritis. It consists of 24 items divided into three domains: Pain (5 items), Stiffness (2 items), and Physical.Function (1 7 items). The WOMAC is widely used to evaluate the impact of osteoarthritis on daily activities and quality of life.Higher WOMAC scores indicate greater pain, stiffness, and functional disability, whereas lower scores represent betterfunctional status and symptom improvement. |
Baseline and 6 weeks post treatment
|
|
Goniometer
Tidsramme: Baseline and 6 weeks post treatment
|
A goniometer is a reliable clinical tool used to measure knee flexion and extension ROM in patients with knee osteoarthritis, assess joint mobility, monitor disease progression, and evaluate rehabilitation outcomes. Normal knee flexion is approximately 135°-140° and extension is 0°. Reduced ROM indicates stiffness, pain, or functional limitations. |
Baseline and 6 weeks post treatment
|
|
Handheld Dynamometer
Tidsramme: Baseline and 6 weeks post treatment
|
A handheld dynamometer (HHD) is a portable, objective tool used to measure isometric muscle strength at a fixed joint position. It records maximum muscle force in Newtons (N) or kilograms-force (kgf), with higher values indicating greater muscle strength. |
Baseline and 6 weeks post treatment
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Short form 1 2 Health Survey
Tidsramme: Baseline and 6 weeks post treatment
|
The SF-12 is a validated, reliable, and shorter version of the SF-36 that assesses physical (PCS) and mental (MCS) components of quality of life in knee osteoarthritis patients. Lower baseline scores indicate physical impairment or emotional burden, while increased post-intervention scores reflect improved physical and mental health. A change of approximately 3-5 points may be considered clinically meaningful, depending on the population and scoring method. |
Baseline and 6 weeks post treatment
|
Samarbejdspartnere og efterforskere
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Neurologiske manifestationer
- Muskuloskeletale sygdomme
- Gigt
- Ledsygdomme
- Reumatiske sygdomme
- Slidgigt
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Smerte
- Slidgigt, knæ
- Motorisk aktivitet
- Bevægelse
- Muskuloskeletale fysiologiske fænomener
- Muskuloskeletale og neurale fysiologiske fænomener
- Terapeutik
- Fysioterapimodaliteter
- Patientpleje
- Træningsterapi
- Rehabilitering
- Efterpleje
- Kontinuitet i patientpleje
- Fysisk konditionering, menneske
- Øvelse
- Modstandstræning
Andre undersøgelses-id-numre
- RE-169-2026
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-delingstidsramme
6 months after the publication of the manuscript
IPD-delingsadgangskriterier
The data can be requested from the corresponding author.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- ICF
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .